Cargando…
Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD–MBD Model Rats by Targeting FGF23-Klotho Signaling Axis
Background: Recently, chronic kidney disease (CKD)-mineral and bone disorder (MBD) has become one of common complications occurring in CKD patients. Therefore, development of a new treatment for CKD–MBD is very important in the clinic. In China, Fucoidan (FPS), a natural compound of Laminaria japoni...
Autores principales: | Liu, Bu-Hui, Chong, Fee-Lan, Yuan, Can-Can, Liu, Ying-Lu, Yang, Hai-Ming, Wang, Wen-Wen, Fang, Qi-Jun, Wu, Wei, Wang, Mei-Zi, Tu, Yue, Wan, Zi-Yue, Wan, Yi-Gang, Wu, Guo-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941278/ https://www.ncbi.nlm.nih.gov/pubmed/33708111 http://dx.doi.org/10.3389/fphar.2020.586725 |
Ejemplares similares
-
Fucoidan Alleviates Renal Fibrosis in Diabetic Kidney Disease via Inhibition of NLRP3 Inflammasome-Mediated Podocyte Pyroptosis
por: Wang, Mei-Zi, et al.
Publicado: (2022) -
PTH, FGF-23, Klotho and Vitamin D as regulators of calcium and phosphorus: Genetics, epigenetics and beyond
por: Portales-Castillo, Ignacio, et al.
Publicado: (2022) -
Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients
por: Silva, Ana Paula, et al.
Publicado: (2019) -
Prevention and Treatment of CKD-MBD
por: Cozzolino, Mario
Publicado: (2013) -
FGF23 Actions on Target Tissues—With and Without Klotho
por: Richter, Beatrice, et al.
Publicado: (2018)